Ischemic Optic Neuropathy Decompression Trial (IONDT)
NCT00000127 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2010-03-24
Summary
To assess the safety and efficacy of optic nerve sheath decompression surgery for non-arteritic ischemic optic neuropathy (NAION).
Conditions
- Ischemic Optic Neuropathy
Interventions
- PROCEDURE
-
Optic Nerve Sheath Decompression Surgery
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-10-31
- Completion
- 1994-10-31
More Related Trials
-
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
NCT00308542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
NCT01260324 ·Status: COMPLETED
-
Citicoline Effect on Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
NCT03046693 ·Status: COMPLETED ·Phase: PHASE4
-
NAION Treatment With Oral Prednisolone and Erythropoietin Injection
NCT03715881 ·Status: UNKNOWN ·Phase: PHASE2
-
Diabetic Retinopathy Study (DRS)
NCT00000160 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy
NCT02439866 ·Status: UNKNOWN ·Phase: PHASE3
-
Traumatic Optic Neuropathy Treatment Trial (TONTT)
NCT01783847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
NCT01975324 ·Status: COMPLETED ·Phase: PHASE4
-
The Therapeutic Effect of Dysthyroid Optic Neuropathy
NCT04096612 ·Status: UNKNOWN ·Phase: NA
-
The Course of Response to Focal Photocoagulation for DME
NCT00442156 ·Status: COMPLETED
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION
NCT02329288 ·Status: UNKNOWN ·Phase: PHASE3
-
Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).
NCT00331253 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
NCT00367133 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal and Intracameral DEX in NPDR
NCT06951087 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery
NCT00801450 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
NCT00071227 ·Status: COMPLETED ·Phase: PHASE1
-
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
NCT01411657 ·Status: COMPLETED ·Phase: PHASE1
-
Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
NCT05138029 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
NCT00464685 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
NCT00069056 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03112005 ·Status: COMPLETED
-
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
NCT00369486 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
NCT02638714 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2